IDEXX Laboratories Inc. (Nasdaq: IDXX) on Wednesday posted revenues of $964 million for the first quarter of 2024, a 7% increase over the same period last year as reported and on an organic basis. Read more
IDEXX Labs reports strong revenue growth for Q1, adjusts 2024 outlook
Related Posts
Bar Harbor approves Jackson Lab’s $33M expansion for rare disease research
The Bar Harbor Planning Board has approved a plan by the Jackson Laboratory to build a 20,000-square-foot expansion to its Rare Disease Translational...
Bigelow lab receives $7 million for algae research, business development
Researchers at Bigelow Laboratory for Ocean Sciences believe algae can make a big splash in the agricultural, aquaculture and pharmaceutical industries,...
Should Maine create a public medical school? UMaine System will study the question
The University of Maine System said this week it will work with a national consultant to study the feasibility of launching the state’s...